CHO Pharma, Inc.

As of June 30, 2026, CHO Pharma, Inc. carries a market capitalization of 28.36B, placing it among publicly traded companies globally. Its enterprise value stands at 26.40B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, CHO Pharma, Inc. has 214.01M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, CHO Pharma, Inc. maintains a current ratio of 21.96, meaning it holds 22.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, CHO Pharma, Inc.'s stock has gained approximately 198.20% over the past 52 weeks. The 50-day moving average sits at 109.33, while the 200-day moving average is 72.15.

As of June 30, 2026, CHO Pharma, Inc. holds 1.96B in cash and equivalents against 7.33M in total debt, resulting in a net debt position of -60.25M. Total book value stands at 2.37B, with working capital of 1.93B providing operational flexibility.